InvestorsHub Logo
Followers 94
Posts 11317
Boards Moderated 0
Alias Born 11/02/2003

Re: pharmeng post# 6806

Monday, 04/06/2015 8:03:51 PM

Monday, April 06, 2015 8:03:51 PM

Post# of 27433
100% of all start ups in the biotechnology business are up on future earnings ,and most aren't even selling product , Cytosorbents is a rare one ,that is selling product overseas while waiting on FDA approval, a very low Market cap, this will change very soon, and everyone will be surprised again and wished they didn't sell and had bought at these levels , institutions will be buying a lot here at these bargain basement prices.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News